APGE (NASDAQ: APGE) insider files to sell 35,200 shares via 10b5-1 plan
Rhea-AI Filing Summary
APGE insider Carl Dambkowski has filed a Form 144 to sell 35,200 shares of common stock. The planned sale is through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $2,754,400.00, based on 68,320,229 shares outstanding.
The securities to be sold include 26,400 common shares acquired on 01/07/2026 through the exercise of stock options for cash, and 8,800 common shares originally received as restricted stock awards on 09/16/2022.
Over the past three months, 10b5-1 plan sales for Dambkowski included 10,900 common shares sold on 12/04/2025 for $817,528.34, and additional sales on 11/05/2025 of 8,060 shares for $443,860.98 and 2,725 shares for $150,064.66. By signing, the seller represents they are not aware of undisclosed material adverse information about APGE.
Positive
- None.
Negative
- None.
FAQ
What does the APGE Form 144 filing disclose?
The Form 144 discloses that Carl Dambkowski, an insider of APGE, plans to sell 35,200 shares of APGE common stock on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,754,400.00.
Which broker and exchange are involved in the APGE Form 144 sale?
The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are listed to be sold on the NASDAQ exchange.
What representation does the APGE insider make in the Form 144?
By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information regarding the current and prospective operations of the issuer that has not been publicly disclosed. The form also references use of a Rule 10b5-1 trading plan if applicable.